Metabolon, founded in Durham, United States, is a pioneering company in the field of metabolomics. Their core mission is to advance biomarker discovery, diagnostic testing, and precision medicine through their powerful phenotyping technology. Metabolon offers comprehensive metabolomics services that provide deep insights into biological systems, aiding in the development of new diagnostics and therapeutic strategies. Their market focus includes healthcare, pharmaceuticals, and biotechnology sectors.
Notable figures affiliated with Metabolon include a team of over 45 PhDs and a history of collaboration with leading research institutions. The company has completed over 10,000 projects and has been cited in more than 3,000 publications. Metabolon's key achievements include significant contributions to biomarker discovery and precision medicine, impacting both clinical research and patient care. Their work has established them as a global leader in metabolomics, driving innovation and improving health outcomes worldwide.
